Mao Zhen, Li Feng, Ge Lige, Hou Wenpeng, Ding Yushen, Wang Feifei, Wen Yujie, Wang Xueqi, Cheng Yongying, Hou Weiwei, Wang Lu, Shi Xinke, Bo Qijing, Dong Fang
The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, No.5 Ankang Lane, Dewai Avenue, Beijing, Xicheng District, 100088, China.
Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, 100069, China.
BMC Psychiatry. 2025 May 15;25(1):493. doi: 10.1186/s12888-025-06950-w.
This study evaluated the utility of serum NR1 and NR2 concentrations in identifying individuals with first-episode schizophrenia (FES) and clinical high risk (CHR) as well as their correlations with clinical symptoms and cognitive domains.
This cross-sectional study compared peripheral blood NR1 and NR2 concentrations among the FES, CHR, and healthy control (HC) groups and examined their association with cognitive function. Serum concentrations of NR1 and NR2 subunits were measured using ELISA, and cognitive function was assessed using the MATRICS Consensus Cognitive Battery. Concentrations were compared among groups using the analysis of covariance or non-parametric tests and ROC curve analysis, and correlation was determined using the Pearson or Spearman method.
A total of 41 FES cases, 34 CHR cases, and 41 HC were included in the study. Serum NR1 concentrations significantly varied among the three groups (Z = 16.19, P < 0.001) and were significantly different between the FES group and the CHR (Z = -4.04, P < 0.001) and HC groups (Z = -2.49, P = 0.01). Additionally, serum NR2 concentration was significantly different between the CHR and HC groups (F = 5.37, P = 0.02). In the FES group, serum NR1 concentration was negatively correlated with speed of processing (r = -0.41, P = 0.02), whereas serum NR2 concentration was negatively correlated with verbal learning (r = -0.40, P = 0.02). In the CHR group, serum NR1 concentration was positively correlated with the total MCCB score (r = 0.40, P = 0.04). ROC curve analysis showed that NR2 level was better for discriminating FES (AUC: 69%; sensitivity: 56%; specificity: 85%; optimal cutoff value: 32.80 ng/mL) and CHR (AUC: 74%; sensitivity: 62%; specificity: 85%; optimal cutoff value: 32.77 ng/mL).
Serum NR1 and NR2 concentrations show potential for early identification of individuals with psychosis, but further validation is needed, and they are also correlated with cognition. Furthermore, serum NR2 concentration is more stable and serves as a promising objective biomarker for quantitative assessment.
本研究评估了血清NR1和NR2浓度在识别首发精神分裂症(FES)和临床高危(CHR)个体中的效用,以及它们与临床症状和认知领域的相关性。
这项横断面研究比较了FES组、CHR组和健康对照组(HC)外周血中NR1和NR2的浓度,并研究了它们与认知功能的关联。使用酶联免疫吸附测定法(ELISA)测量血清中NR1和NR2亚基的浓度,使用MATRICS共识认知成套测验评估认知功能。使用协方差分析或非参数检验以及ROC曲线分析比较各组之间的浓度,并使用Pearson或Spearman方法确定相关性。
本研究共纳入41例FES患者、34例CHR患者和41名HC。三组之间血清NR1浓度存在显著差异(Z = 16.19,P < 0.001),FES组与CHR组(Z = -4.04,P < 0.001)和HC组(Z = -2.49,P = 0.01)之间也存在显著差异。此外,CHR组和HC组之间血清NR2浓度存在显著差异(F = 5.37,P = 0.02)。在FES组中,血清NR1浓度与加工速度呈负相关(r = -0.41,P = 0.02),而血清NR2浓度与言语学习呈负相关(r = -0.40,P = 0.02)。在CHR组中,血清NR1浓度与MCCB总分呈正相关(r = 0.40,P = 0.04)。ROC曲线分析表明,NR2水平在区分FES(AUC:69%;敏感性:56%;特异性:85%;最佳截断值:32.80 ng/mL)和CHR(AUC:74%;敏感性:62%;特异性:85%;最佳截断值:32.77 ng/mL)方面表现更佳。
血清NR1和NR2浓度在早期识别精神病个体方面具有潜力,但需要进一步验证,并且它们也与认知相关。此外,血清NR2浓度更稳定,是一种有前景的用于定量评估的客观生物标志物。